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Women seeking to become pregnant and pregnant women are currently advised
to consume high amounts of folic acid and other methyl donors to prevent neural
tube defects in their offspring. These diets can alter methylation patterns of several
biomolecules, including nucleic acids, and histone proteins. Limited animal model data
suggests that developmental exposure to these maternal methyl supplemented (MS) diets
leads to beneficial epimutations. However, other rodent and humans studies have yielded
opposing findings with such diets leading to promiscuous epimutations that are likely
associated with negative health outcomes. Conflict exists to whether these maternal diets
are preventative or exacerbate the risk for Autism Spectrum Disorders (ASD) in children.
This review will discuss the findings to date on the potential beneficial and aversive
effects of maternal MS diets. We will also consider how other factors might influence the
effects of MS diets. Current data suggest that there is cause for concern as maternal MS
diets may lead to epimutations that underpin various diseases, including neurobehavioral
disorders. Further studies are needed to explore the comprehensive effects maternal MS
diets have on the offspring epigenome and subsequent overall health.
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INTRODUCTION
Mounting evidence suggests that developmental exposure to
extrinsic factors (e.g., diet, chemical exposure, and stress) leads
to pronounced epigenetic and phenotypic effects, commonly
referred to as the “developmental origin of health and disease
(DOHaD)” (Barker, 1997; Hanson and Gluckman, 2011; Barouki
et al., 2012; Rosenfeld, 2012). Epigenetic changes are meioti-
cally and mitotically heritable and include DNA methylation,
histone protein modifications, chromatin re-arrangement, and
non-coding RNAs (Rosenfeld, 2010).
Methylation of CpG sites is a potent regulator of gene expres-
sion, and this process is affected by various external, including
dietary, factors. There has been growing interest in the poten-
tial protective effects that dietary supplements might exert on
these epigenetic marks. Such nutraceuticals include molecules
that directly lend methyl donors in the methyl activation cycle
or serve as cofactors in these pathways, such as methionine,
pyridoxine (vitamin B6), folate (vitamin B9), betaine (trimethyl-
glycine), choline, Vitamin B12, and zinc (Figure 1). Many of
these compounds are included in periconceptional/ prenatal vita-
mins, due to their ability to prevent neural-tube and other
CNS defects in developing fetuses and other health benefits.
While all of these factors exert key roles, emphasis has been
placed on folic acid, wherein women are recommended to
consume a multivitamin containing 0.8mg of folic acid 1 month
prior to conception and throughout the first few months of
pregnancy (http://www.uspreventiveservicestaskforce.org/uspstf/
uspsnrfol.htm; Wolff et al., 2009a,b; Steenblik et al., 2011).
Animal model studies have examined how maternal methyl
supplemented (MS) diets impact the epigenome and/or phe-
notypic outcomes in developing offspring (Table 1A). Some of
these studies have reported favorable effects of these diets on
overall health. Other studies, though, have reported detrimental
maternal MS alterations. Limited studies have examined link-
ages between maternal MS diets and epimutations/disease in her
children (Table 1B).
Other factors likely interact with maternal diet to influence the
net effect of these diets. Examples include genetic background,
sex, developmental windows of exposure, and tissue/cell-specific
vulnerabilities, which are discussed below.
MATERNAL METHYL SUPPLEMENTED DIETS AND
OUTCOMES IN ANIMAL MODEL STUDIES
One of the first reports linking environmental exposure to epimu-
tations suggested that for a specific genotype (Avy/a offspring),
pregnant a/a female mice exposed to the endocrine disrupting
compound (EDC) bisphenol A (BPA) gave birth to a greater
percentage of yellow coat color compared to brown coat color
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FIGURE 1 | Nutritional methyl-supplements and the DNA methylation
reaction. Methyl groups, either synthesized via the folate cycle or donated
directly from betaine, are activated by the methyl activation cycle. Activated
methyl groups are used to methylate cytosine residues of DNA. Both
vitamin B12 and zinc are cofactors used in the transfer of methyl groups.
Compounds listed in bold and underlined are methyl donors or cofactors
included in various methyl supplemented diets. Select enzymes involved in
this pathway, including MTHFR, where single nucleotide polymorphisms
(SNP) variant genotypes have been documented (as detailed in the
manuscript) are shaded.
(Avy/a) offspring (Dolinoy et al., 2007), although we were not able
to reproduce these BPA-induced results (Rosenfeld et al., 2013).
Nonetheless, this first report indicated that offspring of both BPA-
exposed and control animals are genetically identical but differ
epigenetically in the DNAmethylation status in at least one allele,
Avy, encoding for the agouti signaling protein (ASIP) (Dolinoy
et al., 2007). Humans do not possess this allele, but ASIP is abun-
dantly expressed in human adipose tissue and pancreas, where
it has been linked with obesity and type 2 diabetes (Mynatt and
Stephens, 2001; Voisey and Van Daal, 2002).
When the cryptic promoter derived from the retroviral
intracisternal A particle (IAP) within this allele is hypomethy-
lated, Avy is expressed ectopically and constitutively resulting
in yellow coat color mice who are prone to developing these
metabolic disorders. In contrast, if the IAP promoter remains
methylated, it is non-functional, leading to pseudoagouti (brown)
coat color animals that are concomitantly less prone to these
adult diseases. Combined prenatal treatment with a BPA and
methyl-supplemented diet in these females was reported to offset
the BPA-induced shift in coat color distribution from metabolic
deleterious yellow morphs to an increase in brown coat color,
healthier offspring (Dolinoy et al., 2007). Earlier reports indicated
that a/a females harboring Avy/a who were fed a methyl-enriched
diet 2 weeks prior to conception through weaning gave birth to
a greater percentage of brown coat color offspring (Wolff et al.,
1998; Cooney et al., 2002; Waterland and Jirtle, 2003).
Methyl diet supplementation can interact with epigenotype
(Avy/a status) over several generations (through F5) to increase
percentage of pseudoagouti animals possessing a methylated IAP
promoter site (Cropley et al., 2012). However, removal of MS
in later generations led to reversal of this phenotypic distor-
tion. While a MS diet did not increase 5-methylcytosine lev-
els over six generations in C57Bl6J mice, this diet increased
the stochastic epigenetic variation in several loci with effects
becoming more pronounced in later generations on this diet (Li
et al., 2011). Combined results suggest that MS diets lead to epi-
genetic variability over time and may account for altered disease
risk, although no harmful multigenerational phenotypic effects
were reported in C57Bl6J or Avy/a mice (Li et al., 2011; Cropley
et al., 2012).
Mice deficient for twisted gastrulation (TWSG1), an extra-
cellular modulator of bone morphogenetic protein signaling,
exhibit midline facial and jaw defects. However, maternal MS diet
prevented their jaw defects (Billington et al., 2013). Similarly, a
maternal MS diet alleviated atherosclerosis in ApoE homozygous
mutant mice and corresponding elevation of Ccr2, production of
inflammatory cytokines, and restoration of the HDL to LDL ratio
(Delaney et al., 2013). Maternal choline supplementation of mice
has also been reported to abolish transcriptional defects in genes
related to cell growth and metabolism and reduced weaning
body weight that are typically observed in fetal toxic milk (tx-j)
mice, a model of Wilson Disease (an autosomal recessive disorder
leading to hepatic copper accumulation) (Medici et al., 2014).
This maternal supplement may also improve spatial mapping
and basal forebrain cholinergic neuron numbers in Ts65Dn mice
(Ash et al., 2014).
Combined treatment of pregnant rodent dams with methyl
supplements has been reported to mitigate harmful effects of a
high fat diet, including metabolic, select behavioral, DNA methy-
lation, and gene expression effects (Carlin et al., 2013). Maternal
MS may also reverse alcohol-induced DNA methylation Igf2
changes (Downing et al., 2011).
Maternal MS diet in rats resulted in decreased offspring con-
centration of leptin and hypermethylation of the leptin (Ob)
promoter (Giudicelli et al., 2013). Both offspring sexes exhib-
ited impaired post-natal growth, and males showed increased
long-term body weight gain.
No animal model study to date, however, has considered the
long-term impact of exposure to these supplements. Moreover,
current diet recommendations are based on the premise that
many diseases are triggered by hypomethylation of discrete CpG
sites. However, only two animal models to date have linked
epimutations in DNA methylation to maternal MS diet exposure:
viable yellow mice (Avy/a) with metabolic disorders, discussed
above, and AxinFu mice exhibiting tail dysmorphogenesis, or
“kinky” tail (Waterland et al., 2006; Rosenfeld, 2010). Both exam-
ples are the result of DNA methylation alteration in a specific
gene-embedded retroviral particle, IAP. It is unlikely that con-
sumption or maternal exposure to MS selectively targets a single
locus within the genome. Instead, such nutritional supplements
may induce widespread and promiscuous effects. The developing
fetus is especially vulnerable to these changes, as this is when there
is re-establishment of new epigenetic marks and programming of
the primordial germ cells. It is thus not surprising that there are
also mounting animal model studies reporting deleterious effects
in offspring born to dams on a MS diet.
Combined exposure of mouse fetuses to arsenic and mater-
nal MS, in the form of folate, led to more pronounced DNA
methylation changes in the liver and corresponding impaired
fetal development and body weight gain (Tsang et al., 2012).
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Maternal folic acid supplementation along with a high fat diet
increased glucose intolerance and insulin resistance in male mice
offspring (Huang et al., 2014). Another study in mice indi-
cated that a maternal MS diet resulted in harmful and persistent
changes in offspring gut microbiota populations, colonic mucosal
DNA methylation, and gene expression changes, and increased
incidence of colitis compared to control offspring (Schaible et al.,
2011). A similar maternal dietary regimen increased the incidence
of allergic airway disease in mice with corresponding hyperme-
thylation of Runx3, a gene that suppresses allergic airway disease
(Hollingsworth et al., 2008). This same maternal diet suppressed
proinflammatory signals in mice (Delaney et al., 2012).
Treatment of rat dams fed a methyl donor, choline supple-
mented, or deficient diet resulted in selective fetal DNA methyla-
tion and histone protein marks (Davison et al., 2009). A maternal
choline deficient diet resulted in hypermethylation of fetal G9a
and Suv39h1 relative to controls. Coincident with this hyper-
methylation, modified histones associated with transcriptional
silencing, H3K9Me2 and H3K27Me3, increased with maternal
choline supplementation. In contrast, the histonemark associated
with active promoters, H3K4Me2, surged in expression with the
choline-deficient maternal diet.
Gestational and postnatal exposure (in case of pup assess-
ments) to high concentrations of folic acid resulted in new-
born mouse pups exhibiting disrupted cerebral gene expres-
sion for transcripts and their protein products implicated in
normal neural development (Barua et al., 2014). These mater-
nal MS pups also exhibited behavioral alternations (increased
ultrasonic vocalizations, heightened anxiety-like, and hyperactive
behaviors).
HUMAN EPIDEMIOLOGICAL STUDIES LINKING MATERNAL
MS DIETS AND OFFSPRING EPIMUTATIONS
Increased maternal intake during the periconceptional period of
choline was inversely correlated with umbilical cord bloodmethy-
lation of her sons (Boeke et al., 2012). Consumption of folic acid
supplements by pregnant women after 12 weeks of gestation has
been linked to epigenetic changes in fetal cord blood, includ-
ing increased methylation of the paternally expressed IGF2 gene
and decreased methylation of the similarly imprinted PEG3, as
well as LINE-1s (Haggarty et al., 2013). These results thus sug-
gest that a maternal MS diet can influence expression of both
repeat elements and imprinted genes in offspring. The long term
phenotypic effects of such changes, however, remain unknown.
In women, maternal folic acid supplementation has been linked
to decreased incidence of preeclampsia and small for gestational
age births (Kim et al., 2014). On the other hand, maternal
supplementation of folic acid beginning at the first trimester
increased the likelihood of infant bronchiolitis (Veeranki et al.,
2014).
A recent study of Gambian women and their children demon-
strated that consumption of a methyl enriched diet during preg-
nancy strongly correlated with persistent and systemic epigenetic
changes in several metastable epialleles in offspring (Dominguez-
Salas et al., 2014). This relatively large (24 villages, 166 women),
2 years study suggests a strong association between maternal
methyl donor consumption and DNA methylation patterns in
the genomes of offspring, which may ultimately result in adverse
phenotypic outcomes.
LINKAGE OF MATERNAL METHYL SUPPLEMENTED DIETS
AND PREVENTION/RISK FOR ASD IN HER CHILDREN
Although maternal supplementation with folic acid and other
methyl donors contained within pre-natal vitamins has been
promoted as a protection against Autism Spectrum Disorders
(ASD) in children (Schmidt et al., 2011, 2012), other studies sug-
gest an opposite correlation (Rogers, 2008; Leeming and Lucock,
2009; Beard et al., 2011). The study suggesting that maternal
MS diets prevented ASD was based on a cohort population of
288 children that ranged from 24 to 60 months of age and
found an associated greater risk for ASD in children of moth-
ers who did not consume prenatal vitamins supplemented with
methyl components during the periconceptional period (Schmidt
et al., 2011). A follow-up study by this same group further sug-
gested that consumption of folic acid by women beginning at the
periconceptional period may reduce the risk for ASD in moth-
ers and children with inefficient folate metabolism, i.e., a single
nucleotide polymorphism (SNP) in methylenetetrahydrofolate
reductase (MTHFR 677 C>T variant genotype). This enzyme
catalyzes the conversion of 5,10-methylenetetrahydrofolate (5′,10,
′-MTHF) to 5-methyltetrahydrofolate (5′-MTHF, Figure 1) and is
thus the rate-limiting enzyme in the methyl cycle (Schmidt et al.,
2012).
In contrast, a study that employed ASD incidence rates from
the Rochester Epidemiological Project in Rochester, MN, which
spanned decades from 1976–1997, suggested a strong correlation
(0.87) for maternal consumption of prescription prenatal vita-
mins (containing > 1mg of folic acid) and ASD incidence in
offspring (Beard et al., 2011). Consequently, the investigators con-
cluded that too much folic acid might disrupt brain development
and thus increase the risk for ASD, a hypothesis promoted in
previous studies (Rogers, 2008; Leeming and Lucock, 2009).
MATERNAL METHYL SUPPLEMENTED DIETS LIKELY LEAD
TO SYSTEMIC EFFECTS
Select animal model and human epidemiological studies high-
light the primary concern withmaternal and adult methyl supple-
mented diet regimens (Tables 1A and B). Methyl-enriched nutri-
tional compounds mediate one-carbon metabolism (Figure 1)
and thereby increase the availability of S-adenosylmethionine
(SAM). SAM serves as the primary donor of methyl groups to
a wide range of biomolecules, including nucleic acids and histone
proteins. Therefore, it is not possible with this dietary approach
to target specific biomolecules for prevention and remediation
strategies. In some cases, these diets might induce hypermethyla-
tion and suppression of harmful sites, such as embedded retroele-
ments and proto-oncogenes. However, tumor suppressor and
other disease-suppressing genes might also become entrapped in
this DNA methylation “net” and transcriptionally silenced. In
other words, tinkering with methylation status on the global level,
as likely occurs with consumption of methyl supplements, can
affect both “beneficial” and “harmful” genes. The scale of dis-
ease promotion or prevention is likely tipped one way or another
depending on the combined genes that are affected.
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Table 1A | Animal model studies linking maternal MS diets and effects on offspring health and disease.
Publication Animal model Dosing regimen Major findings
Dolinoy et al.,
2007
a/a and Avy /a
mice
Two weeks prior to mating and throughout
gestation and lactation, a/a female mice carrying
Avy /a mice offspring were fed an AIN93G, AIN93G
+ bisphenol A (50mg BPA/kg feed weight) or AIN
93G diet supplemented with BPA (50mg /kg feed
weight) and methyl supplemented (MS, including
4.3mg of folic acid/kg feed weight, 0.53mg of
vitamin B12/kg feed weight, 5 g of betaine/kg feed
weight, and 7.97 g of choline chloride/kg feed
weight) diet.
Those females exposed to the BPA diet alone were
reported to give birth to greater percentage of
yellow coat color Avy /a offspring, who are prone to
developing metabolic disorders. In contrast,
females exposed to the combined diet gave birth
to equivalent percentage of brown to yellow coat
color Avy /a offspring, suggesting that the maternal
MS diet abolished the harmful effects of BPA in
this epigenetic animal model.
Wolff et al.,
1998; Cooney
et al., 2002
a/a and Avy /a
mice
The a/a dams were placed on a control (NIH-31
diet) 3SZM diet 2 weeks prior to mating to Avy /a
males and through parturition. Those receiving the
methyl supplemented diet were then divided into
those that received the MS diet for 1 week after
birth followed by a lower dose of methyl
supplements (HS diet) for the second week after
birth and the NIH-31 thereafter. Other dams were
placed on the MS diet 2 weeks prior to mating, HS
diet for 1 week after birth followed by the NIH-31
thereafter. Methyl components in the 3SZM diet
included: 15 g choline, 15 g betaine, 15mg folic
acid, 1.5mg vitamin B12, 7.5mg L-methionine, and
150mg zinc. MS diet included 5 g choline, 5 g
betaine, 5mg folic acid, and 0.5mg vitamin B12.
Those in the HS diet included: 2.5 g choline, 2.5 g
betaine, 2.5mg folic acid, and 0.25mg vitamin B12.
The combined studies indicated that maternal MS
of a/a mice carrying Avy /a offspring increases the
DNA methylation status of long terminal repeat
(LTR) controlling agouti (A) expression and thereby,
increasing the percentage of pseudoagouti coat
color relative to yellow coat color Avy /a offspring
with the former generally remaining healthy
throughout their lifespan.
Waterland and
Jirtle, 2003
a/a and Avy /a
mice
The a/a females were placed on a control (NIH-31)
or NIH-31 diet supplemented with methyl
donors/cofactors (same as in Wolff et al., 1998) 2
weeks prior to mating to Avy /a males and
throughout gestation and lactation.
These finding supported the earlier work of Wolff
et al., 1998; Cooney et al., 2002 in that that it
showed that MS to a/a carrying Avy /a offspring
increased the percentage of pseudoagouti
offspring by increasing the CpG methylation of the
Avy locus.
Cropley et al.,
2012
a/a and Avy /a
mice
Two weeks prior to breeding and through weaning
of the F5 generation, Avy /a males and a/a females
were placed on a control (NIH-31) or this diet
supplemented with methyl donors/cofactors: 15 g
choline, 15 g betaine, 7.5 g L-methionine, 150mg
ZnSO4, 15mg folic acid, and 1.5mg vitamin B12.
From weaning of F5 generation through F8
generation, all animals were placed on a control
(NIH-31) diet.
MS increased proportion of pseudoagouti offspring
through the F5 generation. However, removal of
the MS diet in the F5 generation resulted in a
return to the distribution of pseudoagouti to brown
coat color Avy /a mice, suggesting that the
epigenetic status of the germline of Avy are
reversible after MS removal.
Li et al., 2011 C57Bl6J Two weeks prior to mating initial pair through six
generations, C57Bl6J males and females were
placed either on a NIH-31 control diet or this diet
supplemented with methyl donors/cofactors: 15 g
choline, 15 g betaine, 7.5 g L-methionine, 150mg
zinc, 15mg folic acid, and 1.5mg vitamin B12.
MS increased the stochastic epigenetic variation in
several loci with the effects becoming more
pronounced in later generations.
Billington
et al., 2013
Mice deficient
for twisted
gastrulation
(Twsg1)
Females carrying mice deficient in this gene were
fed a control (NIH-31) or MS diet that included
folate, vitamin B12, choline, and betaine (Harlan
Teklad-TD.01308) 2 weeks prior to mating and
throughout gestation and lactation.
These transgenic deficient mice generally
demonstrate midline facial and jaw defects.
However, maternal MS exposure prevented the
jaw but not midline defects in these mice.
(Continued)
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Table 1A | Continued
Publication Animal model Dosing regimen Major findings
Delaney et al.,
2013
ApoE
homozygous
mutant mice
Females carrying these transgenic mutant mice
were fed a control or MS (11.8 g/kg L-methionine,
13.5mg/kg folic acid, 1560mg/kg B12, 0.72 g/kg
ZnS04.7H20, 0.015 g/kg betaine, and 19.4 g/kg
choline chloride) diet 3 weeks prior to mating and
throughout gestation and lactation. At weaning, all
males were placed on a 42% high fat diet (HFD)
until they were euthanized.
The maternal MS exposure alleviated the
atherosclerosis that would otherwise occur in
these mice. Correspondingly, those exposed to the
diet regimen had inhibition of T lymphocyte
expression of Ccr2, reduction in other
inflammatory cytokines, and increased circulating
HDL to LDL ratio.
Ash et al.,
2014
Ts65Dn female
mice (a mouse
model for down
syndrome and
Alzheimer’s
disease) and
C57/Bl6J Eicher
X C3H/HeSnJ F1
male mice.
Breeder pairs were randomly assigned to a control
chow-based diet (AIN-76A containing 1.1 g/kg
choline chloride or a choline-supplemented diet
(AIN-76A with 5.0 g/kg choline chloride). Weaned
pups were placed on the control diet.
• Spatial mapping was compromised in control
Ts65Dn mice relative normal disomic (2N)
littermates. However, maternal choline
supplementation improved spatial mapping of
Ts65Dn mice.
• Ts65Dn mice possessed decreased number and
density of medial septal hippocampal basal
forebrain cholinergic neurons (BFCNs) in control
Ts65Dn mice relative disomic littermates. Maternal
chonine supplementation increased the numbers
of these neurons.
Medici et al.,
2014
C3H and tx-j
mice
C3H control females carrying tx-j conceptuses
were fed 2 weeks prior to mating and throughout
gestation (GD17) a control (8mmol/kg choline of
diet) or choline supplemented (36mmol/kg choline
of diet). Other foster C3H females received these
same diets that extended through lactation (21
days postpartum).
Maternal choline supplementation of C3H dams
prevented transcriptional deficits and reduced body
weight at weaning observed in their tx-j offspring.
Carlin et al.,
2013
C57BL/6J mice Bred female mice were exposed to a control
(18.5% protein, 12% fat and 69.5% carbohydrate),
methyl supplemented (15 g choline chloride,15 g
betaine [anhydrous], 15mg folic acid, 1.5mg
vitamin B12, 7.5 g L-methionine, and 150mg zinc
from ZnSO4/7H2O), high fat (HF, 18.5% protein,
60% fat, and 20.5% carbohydrate) diet alone, or a
combination of a HF and MS diet (maternal
obesogenic methyl-supplemented, MOM diet)
throughout gestation and lactation.
The methyl supplements in this diet regimen
mitigated the harmful metabolic, behavioral, DNA
methylation, and gene expression effects of the
high fat component.
Downing
et al., 2011
C57BL/6J mice Two weeks before mating, dams were placed on
an NIH-31 control diet or the 3SZM diet (Wolff
et al., 1998) containing 15 g choline, 15 g betaine,
15mg folic acid, 1.5mg Vitamin B12, 7.5 g
L-methionine, and 150mg zinc. Control and MS
dams were treated with 5.8 g/kg ethanol on
gestational day 9.
• Gestational exposure to ethanol reduced
offspring expression of Igf2.
• Prior and concurrent exposure to a maternal MS
diet abolished these ethanol-induced alterations in
Igf2 expression.
• Maternal MS decreased prenatal mortality,
enhanced prenatal growth, and reduced the
incidence of digit malformations.
Giudicelli
et al., 2013
Sprague Dawley
Rats
Female rats were fed a control or MS (12 g/kg
L-methionine, 15 g/kg choline, 15 g/kg betaine,
1000mg/kg vitamin B12, 15mg/kg folic acid, and
180mg/kg zinc) diet 21 to 28 prior to mating and
throughout gestation and lactation.
• A maternal MS diet decreased circulating
concentrations of leptin and led to
hypermethylation of the Ob promoter in exposed
offspring.
• Exposed male offspring showed increased
long-term body weight gain.
• Exposed male and female offspring had
suppressed post-natal growth.
(Continued)
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Table 1A | Continued
Publication Animal model Dosing regimen Major findings
Tsang et al.,
2012
CD1 Mice Pregnant mice were fed a control or 11mg/kg folate
supplemented diet. Some members of both
groups were then subjected from gestational day
(GD)1 to GD18 to water containing Arsenic (As, 85
ppm).
Mouse fetuses at GD18 exposed to a maternal diet
containing arsenic and MS demonstrated more
pronounced hepatic DNA methylation changes and
impaired fetal development and body weight gain
compared to those exposed to the maternal
arsenic-supplemented diet alone.
Huang et al.,
2014
C57BL/6J Mice Female mice were placed on a control folic acid
2mg folic acid/ kg diet, AIN93G) diet, or this same
diet with the recommended folic acid supplement
(5mg folic acid/kg diet, RF0IS) or high folic acid
(40mg folic acid/kg diet, HFoIS) before and after
pregnancy. At birth, all dams were switched to the
AIN93G control diet, and male weanling pups were
placed on this same diet. Some male offspring
were euthanized at 7 weeks of age; whereas, the
remaining males per group were switched to a
high fat diet until they were euthanized at 15
weeks of age.
• No differences were detected in males from the
various groups euthanized prior to being exposed a
high fat diet.
• After 8 weeks of being on the high fat diet, males
derived from dams on the HfoIS diet had increased
incidence of obesity, glucose intolerance, and
insulin resistance relative to controls.
• HfoIS sons exhibited reduced serum adiponectin
concentrations and corresponding decrease in
adiponectin (AdipoQ) mRNA expression but
increased global DNA hypermethylation in white
adipose tissue compared to control males.
Schaible et al.,
2011
C57BL/6J Mice Females were exposed to a control (NIH-31) or this
diet supplemented with methyl components
(5mg/kg folic acid; 0.5 g/kg vitamin B12; 5 g/kg
betaine; and 5.76 g/kg choline [TD#01308,
Harlan-Teklad]) 2 weeks prior to mating and
throughout gestation and lactation.
A maternal MS diet led to:
• Harmful and persistent changes in the offspring
gut microbiota.
• Offspring colonic mucosal DnA methylation and
gene expression changes.
• Increased incidence of colitis in exposed
compared to control offspring.
Hollingsworth
et al., 2008
C57BL/6J mice Two weeks prior to mating and throughout
pregnancy, females were placed on an NIH-31
control diet or AIN93G diet supplemented with
methyl donors and cofactors (folic acid, Vitamin
B12, choline chloride, betaine, and ZnSO4 X 7H20
for a low methyl diet and a high methyl diet
concentrations not specified in paper and
reference Supplemental Table 1 is not included on
the journal’s website). F1 progeny were placed on
the NIH-31 control diet
Maternal methyl supplementation increased the
incidence of allergic airway disease in her offspring
with corresponding hypermethylation of Runx3, a
gene that has previously been shown to
suppresses allergic airway disease.
Delaney et al.,
2013
C57BL/6J mice Three weeks prior to mating, females were placed
on a NIH-31 control or a maternal
methyl-supplemented diet (13.5mg/kg folic acid,
Vitamin B12 1.56 g/kg, 15mg/kg betaine, and
19.4 g/kg choline chloride). Weaned pups were
either euthanized at 28 days of age or placed on
the control diet
• F1 offspring exposed to the maternal MS were
smaller in size at 28 days of age compared to
controls.
• T-cells from the maternal MS offspring
possessed increased DNA methylation relative to
those from control mice.
• T cells from maternal MS mice exhibited reduced
T cell chemokine receptor (Ccr2 and Ccr5), C-X-C-
chemokine receptor 3, Tnfa, and Il4 gene
expression and associated decreased chemotaxis.
Davison et al.,
2009
Sprague Dawley
Rats
Female rats were fed a control (8mmol/kg choline
chloride), choline-supplemented (36mmol/kg
choline chloride), or choline-deficient (0mmol/kg
choline chloride) diet from GD11 to GD17
A maternal MS (choline) or choline deficient diet
resulted in selective epimutations in DNA
methylation and histone protein marks.
Barua et al.,
2014
C57Bl6J Gestational and post-natal exposure (in case of pup
assessments) to control diet, 0.4mg folic
acid-supplemented diet (lower dose), or 4mg/kg
folic acid-supplemented diet (higher dose)
Higher folic acid-supplemented diet led to:
• Disruptive gene and protein expression changes
in the cerebral hemispheres of newborn pups
• Behavioral abnormalities in neonatal pups,
including increased ultrasonic vocalizations,
anxiety-like, and hyperactive behaviors.
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Table 1B | Human epidemiological studies linking maternal MS diets and effects on offspring health and disease.
Publication Study population/design Major findings
Boeke et al., 2012 Determination of various maternal MS, including choline,
and offspring umbilical cord methylation.
Increased maternal intake during the periconceptional
period of choline was inversely correlated with umbilical
cord methylation in sons but not daughters.
Haggarty et al., 2013 Measurement of folic acid supplements during various
gestational periods, including after 12 weeks of gestation,
and measurements of epigenetic changes in offspring
umbilical cord blood and methylation status of individual
imprinted genes and repeat elements.
Increased consumption of folic acid supplements by
pregnant women after 12 weeks of gestation was linked
to epigenetic changes in fetal core blood, including
increased methylation of the paternal copy of IGF2 and
decreased methylation of the paternally-imprinted PEG3,
as well as repeat elements (LINE-1s).
Kim et al., 2014 A retrospective secondary analysis cohort population
consisting of Korean mother and children dyads was
examined. Pregnancies (215 included in the study) were
delivered at Korea University Anam Hospital between July
1, 2009 and June 13, 2010. Maternal folate level was
measured with an I125-based RIA.
Incidence of preeclamsia and small for gestational age
births was reduced in folic acid supplemented group
compared to control mothers.
Veeranki et al., 2014 A retrospective cohort study that included 167,333 women
(15–44) and their biological infants born during 1995–2007
that were enrolled in the Tennessee Medicaid program
(TennCare) was used for these studies. Infants were
tracked for bronchiolitis in the first year of life.
Maternal supplementation of folic acid through prenatal
vitamins beginning at the first trimester increased the
likelihood of infant bronchiolitis
Dominguez-Salas et al.,
2014
Gambian women and their children representing 24 villages
and 166 women were included in this 2 years study that
examined consumption of maternal methyl donors and
DNA methylation pattern in the offspring genomes.
There was a strong association between maternal
methyl donor supplementation and potentially harmful
DNA methylation alterations in offspring genomes.
Schmidt et al., 2011 Study included children that ranged from 24 to 60 months
of age (N = 288) and examined effects of maternal
consumption of prenatal vitamins containing methyl
components during the periconceptional period and
offspring incidence of ASD.
Increased risk for autism spectrum disorders (ASD) was
identified in children whose mothers did not consume
prenatal vitamins supplemented with methyl
components during the periconceptional period.
Schmidt et al., 2012 Measurement of folic acid intake during the
periconceptional period and ASD risk in mothers and
children, including those that had inefficient folate
metabolism due to a single nucleotide polymorphism (SNP)
in the methyhlenetetrahydrofolate reductase enzyme
(MTHFR 677 C>T variant genotype).
Consumption of folic acid by women beginning at the
periconceptional period was associated with reduced risk
of ASD in mothers and children with inefficient folate
metabolism.
Beard et al., 2011 Rochester Epidemiological Project, Rochester, MN study
that spanned 1976–1997 and examined ASD incidence
rates relative to maternal consumption of folic acid.
A strong correlation (0.87) was evident for maternal
consumption of prescription prenatal vitamins
(containing > 1mg folic acid) and ASD incidence in
offspring.
OTHER FACTORS INFLUENCING THE EPIGENETIC EFFECTS
OF MATERNAL METHYL SUPPLEMENTED DIETS
Genetic variation and other maternal factors may be important
considerations in determining whether specific nutraceuticals are
beneficial. It is clear that there are gene-nutrient interactions in
one-carbon metabolism (Friso and Choi, 2005). As noted, mater-
nal folate supplementation may help to reduce the incidence of
ASD in mothers and children with a MTHFR 677 C>T variant
genotype that leads to inefficient folate metabolism. In contrast,
this same diet may increase the risk for ASD in those with nor-
mal folate metabolism (Rogers, 2008; Leeming and Lucock, 2009;
Beard et al., 2011). Similarly, total intake of choline and mater-
nal genotype in the MTHFR and phosphatidyl ethanolamine
methyltransferase (PEMT) enzymes interact to alter the amount
of choline and choline metabolites in the breast milk, and thereby
the amount of total choline available to the developing infant
(Fischer et al., 2010a). In mothers with genetic polymorphisms
that alter the intake-metabolite concentrations, supplemental
choline might be beneficial. Maternal estrogen concentrations
and gut microbiota populations may also influence the require-
ment for choline supplementation (Fischer et al., 2010b; Spencer
et al., 2011).
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It is possible that not all methyl donors lead to similar epi-
genetic effects across target organs, tissues, and or cell types (as
Reviewed in Ly et al., 2012). For example, diet duration and
potential interactions with other dietary components may be con-
founding factors. While an in-depth comparison is not currently
possible due to limited studies assessing individual methyl com-
ponents, Table 1A provides details on the treatment strategies for
the animal experiments detailed herein. As shown in this Table,
considerable variations in concentrations of methyl donors alone
and in combination with each other have been tested in the dif-
ferent rodent studies. Future experiments need to be designed to
consider the safety of single nutrient vs. nutrient combinations
and a range of doses for each supplement should be tested.
Concurrent exposure to other compounds may also influence
the effects of a methyl supplemented diet. For instance, prenatal
exposure to exogenous glucocorticoids alters placental trans-
port, and subsequently the availability of methyl donors, with an
increased transfer of folate; whereas, choline transport across this
organ was suppressed (Wyrwoll et al., 2012). Correspondingly,
reduced fetal plasma methionine levels were observed in the
glucocorticoid exposed fetuses.
Sexually dimorphic differences might also occur in response
to in utero or adult exposure to methyl supplemented diets, as has
been reported for other diets (Mao et al., 2010). For example, both
maternal folate supplementation and fetal sex influence the DNA
methylation status of Slc394a in the intestinal tract (McKay et al.,
2011). Similarly, maternal methyl-deficient diets selectively result
in metabolic disturbances in male, but not female, rat offspring
(Maloney et al., 2011). A diet deficient in key methyl donors
(choline and methionine) has been linked with hepatic carcino-
genesis in F344 male rats (Mikol et al., 1983; Wilson et al., 1984;
Pogribny et al., 2006); whereas, these dietary deficiencies do not
result in liver cancer in their female counterparts (Saito et al.,
1991).
Lastly, methyl components may lead to tissue/cell-specific
effects. Such differences would suggest that these diets might aide
in disease prevention in select organs or tissues but also exacerbate
disease risk in others. To our knowledge, however, there has not
currently been a comprehensive examination of how a maternal
MS diet affects varying tissues and somatic/germ cells, and thus
impacted phenotypes. This information is critical in determining
the global effects that might be anticipated in offspring born to
mothers on these supplemented diets.
CONCLUSIONS AND FUTURE DIRECTIONS
The notion that “optimal” MS diets might be used for preven-
tion and remediation strategies to treat various human diseases
is gaining currency (Van Den Veyver, 2002). Mounting studies
have reported on effects of maternal MS diets in animal models
and human epidemiological studies. However, there is currently
no consensus on whether these dietary regimens are actually
protective against a range of diseases. While early reports sug-
gested that these diets might be useful in prevention strategies in
epigenetic and transgenic animal models (Dolinoy et al., 2007;
Billington et al., 2013; Delaney et al., 2013; Giudicelli et al., 2013),
subsequent studies in animal models have suggested that mater-
nal MS diets result in widespread epimutations that may govern
diverse diseases (Hollingsworth et al., 2008; Schaible et al., 2011;
Tsang et al., 2012). Additionally, maternal MS diets may alter the
DNA methylation of a myriad of genes, including repetitive ele-
ments and imprinted genes in humans (Haggarty et al., 2013;
Dominguez-Salas et al., 2014). The extent of such epimutations,
and their biological consequences, remain to be determined.
While the idea of an “optimal” maternal MS diet preventa-
tive/treatment strategy is appealing, this diet approach cannot be
used to target selectively a single gene. Instead, indiscriminate and
potentially irreversible methylation changes in a broader range
of biomolecules and cells/tissues may result from such dietary
treatment. Potential disease outcomes are likely tipped one way
or another depending on the fetal sex, maternal/fetal genetic
background, other maternal factors (such as endogenous and
exogenous circulating hormones and the intestinal microbiome),
as well as tissue/cell specificity and concentration and duration
of exposure to these nutritional supplements. All of these fac-
tors should be considered when employing maternal MS diets to
combat fetal disease.
Comprehensive long term animal and human epidemiologi-
cal studies should be undertaken to assess the global effects of
these nutraceuticals and to resolve the current conflicting data
in regards to maternal MS diet. Until then, women request-
ing prenatal/perinatal vitamin support should be advised against
consuming methyl supplements, (e.g., folic acid) in doses that
exceed the current recommendations for preventing fetal neural
tube defects.
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